- Home
- OSUR vs NCA Comparison
OSUR vs NCA Comparison
Compare OSUR & NCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- NCA
- Stock Information
- Founded
- OSUR 2000
- NCA 1987
- Country
- OSUR United States
- NCA United States
- Employees
- OSUR N/A
- NCA N/A
- Industry
- OSUR Medical/Dental Instruments
- NCA Investment Managers
- Sector
- OSUR Health Care
- NCA Finance
- Exchange
- OSUR Nasdaq
- NCA Nasdaq
- Market Cap
- OSUR 289.4M
- NCA 288.4M
- IPO Year
- OSUR 1986
- NCA N/A
- Fundamental
- Price
- OSUR $3.64
- NCA $8.40
- Analyst Decision
- OSUR Hold
- NCA
- Analyst Count
- OSUR 2
- NCA 0
- Target Price
- OSUR $5.50
- NCA N/A
- AVG Volume (30 Days)
- OSUR 1.0M
- NCA 59.6K
- Earning Date
- OSUR 11-06-2024
- NCA 01-01-0001
- Dividend Yield
- OSUR N/A
- NCA 3.92%
- EPS Growth
- OSUR N/A
- NCA N/A
- EPS
- OSUR 0.15
- NCA N/A
- Revenue
- OSUR $224,263,000.00
- NCA N/A
- Revenue This Year
- OSUR N/A
- NCA N/A
- Revenue Next Year
- OSUR N/A
- NCA N/A
- P/E Ratio
- OSUR $24.13
- NCA N/A
- Revenue Growth
- OSUR N/A
- NCA N/A
- 52 Week Low
- OSUR $3.58
- NCA $7.77
- 52 Week High
- OSUR $8.45
- NCA $9.12
- Technical
- Relative Strength Index (RSI)
- OSUR 39.12
- NCA 29.30
- Support Level
- OSUR $3.76
- NCA $8.30
- Resistance Level
- OSUR $3.70
- NCA $8.82
- Average True Range (ATR)
- OSUR 0.17
- NCA 0.11
- MACD
- OSUR -0.02
- NCA -0.03
- Stochastic Oscillator
- OSUR 10.00
- NCA 17.54
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About NCA Nuveen California Municipal Value Fund
Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.